Assessing and Working with Patients with Cognitive Impairment and Dementia
The Carlat Psychiatry Report, Volume 13, Number 3, March 2015
Marc Agronin, MD
Vice President, Behavioral Health and Clinical Research
Miami Jewish Health Systems, Miami, FL
Dr. Agronin has disclosed that he is principal investigator on research grants from several pharmaceutical firms and that all funds go directly to his employer, Miami Jewish Health Systems. In addition, he has been on the speakers bureaus of Forest Laboratories (Namenda XR), AssurX (GeneSightRX), and Novartis (Exelon Patch). Dr. Carlat has reviewed the content of the interview and has determined that there is no bias due to these relationships.
Get advice on how to assess and work with patients with cognitive impairment and dementia, in an interview with Marc Agronin, MD, Geriatric Psychiatrist and Vice President of Behavioral Health and Clinical Research at Miami Jewish Health Systems.